Literature DB >> 18317274

Epileptic syndromes in infancy and childhood.

Rima Nabbout1, Olivier Dulac.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to review new epilepsy syndromes, acquire a new understanding of older ones and emphasize the impact of this concept on basic research regarding aetiology and treatment. RECENT
FINDINGS: In addition to those included in the classification of the International League Against Epilepsy, new epilepsy syndromes comprise febrile seizures plus, benign familial neonatal-infantile seizures (BFNIS), benign infantile focal epilepsy with midline spikes and waves during sleep (BFIS), malignant migrating partial seizures in infancy, devastating epilepsy in school age children and late onset cryptogenic spasms. Genetics played a central role in identifying some new entities (BFNIS, BFIS with choreoathetosis), to delineate older syndromes (Dravet syndrome and myoclonic astatic epilepsy) and determine their mechanisms (infantile spasms, pyridoxine dependent seizures, neonatal encephalopathy with suppression bursts).
SUMMARY: A significant number of children, mainly infants, do not fit in any of the described epilepsy syndromes. Still many patients with infantile epilepsy require the identification of cause or recognition of an epilepsy syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18317274     DOI: 10.1097/WCO.0b013e3282f7007e

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  11 in total

1.  Duplication 16p11.2 in a child with infantile seizure disorder.

Authors:  Jirair K Bedoyan; Ravinesh A Kumar; Jyotsna Sudi; Faye Silverstein; Todd Ackley; Ramaswamy K Iyer; Susan L Christian; Donna M Martin
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

Review 2.  Early-onset epileptic encephalopathies and the diagnostic approach to underlying causes.

Authors:  Su-Kyeong Hwang; Soonhak Kwon
Journal:  Korean J Pediatr       Date:  2015-11-22

Review 3.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 4.  Seizures and epilepsy: an overview for neuroscientists.

Authors:  Carl E Stafstrom; Lionel Carmant
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

5.  "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.

Authors:  Pasquale Parisi; Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Alberto Verrotti; Paola Iannetti; Maria Pia Villa
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.

Authors:  Giulia Barcia; Matthew R Fleming; Aline Deligniere; Valeswara-Rao Gazula; Maile R Brown; Maeva Langouet; Haijun Chen; Jack Kronengold; Avinash Abhyankar; Roberta Cilio; Patrick Nitschke; Anna Kaminska; Nathalie Boddaert; Jean-Laurent Casanova; Isabelle Desguerre; Arnold Munnich; Olivier Dulac; Leonard K Kaczmarek; Laurence Colleaux; Rima Nabbout
Journal:  Nat Genet       Date:  2012-10-21       Impact factor: 38.330

7.  Epileptic encephalopathies in adults and childhood.

Authors:  Zekiye Kural; Ali Fahir Ozer
Journal:  Epilepsy Res Treat       Date:  2012-09-27

Review 8.  Emerging role of the KCNT1 Slack channel in intellectual disability.

Authors:  Grace E Kim; Leonard K Kaczmarek
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

9.  Current trends in the treatment of infantile spasms.

Authors:  Chang-Yong Tsao
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

10.  Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.

Authors:  Rima Nabbout; Nicole Chemaly; Mathilde Chipaux; Giulia Barcia; Charles Bouis; Celia Dubouch; Dorothee Leunen; Isabelle Jambaqué; Olivier Dulac; Georges Dellatolas; Catherine Chiron
Journal:  Orphanet J Rare Dis       Date:  2013-11-13       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.